Risma Lab

Publications

Berges-Gimeno, MP; Alvarez-Cuesta, E; Atanaskovic-Markovic, M; Attanassi, M; Caffareli, C; Caubet, JC; du Toit, G; Guzman-Melendez, A; Kuyucu, S; Madrigal-Burgaleta, R; Valluzzi, RL; Vazquez-Revuelta, P; Watts, TJ; Yamaguchi, M. Drug hypersensitivity reactions in children in clinical practice: A WAO Statement. World Allergy Organization Journal. 2025; 18:101087.

Fernandez, E; Robson, M; Summar, G; Earl, P; Wendling, T; Wessels, M; Norton, AE; Risma, K. Serum sickness-like reactions in children taking antibiotics represent a distressing form of infection-associated urticaria and may recur unpredictably in susceptible children. The Journal of Allergy and Clinical Immunology: in Practice. 2025; 13:1214-1216.e3.

Norton, AE; Risma, K; Ben-Shoshan, M. Serum Sickness-Like Reactions in Children-Is Lifelong Avoidance Indicated?. The Journal of Allergy and Clinical Immunology: in Practice. 2025; 13:969-977.

Day, ME; Duan, Q; Markham, J; Courter, JD; Risma, K; Beck, AF; Haslam, D. P-1133. Preferred (Spoken) Language was a Major Correlate of Disparate Antibiotic Prescribing in the Pediatric Outpatient Setting Throughout the COVID-19 Pandemic. Open Forum Infectious Diseases. 2025; 12:ofae631.1320.

White, AA; Ramsey, A; Guyer, A; Israelsen, RB; Khan, F; Kaplan, B; Kumar, S; Blumenthal, KG; Risma, K; Kakumanu, S; Macy, E. AAAAI Position Statement on Changing Electronic Health Record Allergy Documentation to "Alerts " to Lead to Easily Understood, Actionable Labels. The Journal of Allergy and Clinical Immunology: in Practice. 2024; 12:3237-3241.

McDonnell, J; Cousins, K; Younger, ME M; Lane, A; Abolhassani, H; Abraham, RS; Al-Tamemi, S; Aldave-Becerra, JC; Al-Faris, EH; Alfaro-Murillo, A; Lim, XR; Lopes, JP; López, AL; Tarquini, L. COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report. Journal of Clinical Immunology. 2024; 44:86.

Lanier, K; Scherzer, R; Coletta, C; Ogbogu, PU; Risma, KA; Redmond, M. Factors Influencing Career Choice of Allergy and Immunology Fellows-in-Training: A Work Group Report of the AAAAI Program Directors Assembly Executive Committee. The Journal of Allergy and Clinical Immunology: in Practice. 2024; 12:627-632.e4.

Zhou, ZH; Cortese, MM; Fang, JL; Wood, R; Hummell, DS; Risma, KA; Norton, AE; KuKuruga, M; Kirshner, S; Rabin, RL; Forshee, R; Broder, KR; Anderson, S; Kozlowski, S. Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination. Vaccine. 2023; 41:4183-4189.

Huang, FS; Mangeot, C; Sucharew, H; Simon, K; Courter, J; Risma, K; Schaffzin, JK. Beta-Lactam Allergy Association with Surgical Site Infections in Pediatric Procedures: A Matched Cohort Study. Journal of the Pediatric Infectious Diseases Society. 2023; 12:123-127.

Guarnieri, KM; Xie, SS; Courter, JD; Liu, C; Ruddy, RM; Risma, KA. Distinct Characteristics and Chronology of Amoxicillin-Associated Reactions in Pediatric Acute Care Settings. The Journal of Allergy and Clinical Immunology: in Practice. 2022; 10:2951-2957.e3.

Xie, SS; Guarnieri, KM; Courter, JD; Liu, C; Ruddy, RM; Risma, KA. Predictors of Acute Care Reutilization in Pediatric Patients With Amoxicillin-Associated Reactions. The Journal of Allergy and Clinical Immunology: in Practice. 2022; 10:2958-2966.e3.

Droghini, HR; Abonia, JP; Collins, MH; Milner, JD; Lyons, JJ; Freeman, AF; Mukkada, VA; Risma, KA; Rothenberg, ME; Schwartz, JT. Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency. The Journal of Allergy and Clinical Immunology: in Practice. 2022; 10:1903-1906.

James, AE; West, L; Schloss, K; Nataraj, P; Urban, A; Hirsch, A; Krausz, M; Kumar, S; Raasch, J; Risma, K; Church, JA; Grimbacher, B; Bergerson, JR E; Chong, H; Freeman, AF. Treatment of STAT3-deficient hyper-immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation. The Journal of Allergy and Clinical Immunology: in Practice. 2022; 10:1367-1370.e1.

Dribin, TE; Schnadower, D; Wang, J; Camargo, CA; Michelson, KA; Shaker, M; Rudders, SA; Vyles, D; Golden, DB K; Spergel, JM; Witry, JK; Zhang, Y; Sobolewski, B; Sampson, HA. Anaphylaxis knowledge gaps and future research priorities: A consensus report. Journal of Allergy and Clinical Immunology. 2022; 149:999-1009.

Lehman, HK; Yu, KO A; Towe, CT; Risma, KA. Respiratory Infections in Patients with Primary Immunodeficiency. The Journal of Allergy and Clinical Immunology: in Practice. 2022; 10:683-691.e1.

Risma, KA. COVID-19 mRNA vaccine allergy. Current Opinion in Pediatrics. 2021; 33:610-617.

Xie, SS; Soler, X; Risma, KA. Perioperative anaphylaxis to intravenous vancomycin in a pediatric patient with previous topical exposures. Annals of Allergy, Asthma, and Immunology. 2021; 127:264-266.

Dribin, TE; Schnadower, D; Spergel, JM; Campbell, RL; Shaker, M; Neuman, MI; Michelson, KA; Capucilli, PS; Camargo, CA; Brousseau, DC; Pistiner, M; Witry, JK; Zhang, Y; Sampson, HA. Severity grading system for acute allergic reactions: A multidisciplinary Delphi study. Journal of Allergy and Clinical Immunology. 2021; 148:173-181.

Risma, KA; Edwards, KM; Hummell, DS; Little, FF; Norton, AE; Stallings, A; Wood, RA; Milner, JD. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines. Journal of Allergy and Clinical Immunology. 2021; 147:2075-2082.e2.